Quantitative Analysis of Cell-Based Luciferase Fusion Reporters
- Authors: Khristichenko A.Y.1, Poloznikov A.A.1, Hushpulian D.M.1, Smirnova N.A.1, Zakhariants A.A.2, Kazakov S.V.3, Tishkov V.2,4,5, Gazaryan I.G.1,2,4
-
Affiliations:
- D. Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology of Healtcare Ministry of Russia
- Innovations and High Technologies MSU Ltd
- Department of Chemistry and Physical Sciences, Dyson College, Pace University, Pleasantville
- Moscow State University, Department of Chemistry
- A.N. Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences
- Issue: Vol 74, No 4 (2019)
- Pages: 180-185
- Section: Article
- URL: https://bakhtiniada.ru/0027-1314/article/view/163957
- DOI: https://doi.org/10.3103/S0027131419040047
- ID: 163957
Cite item
Abstract
Cell-based reporters expressing luciferase fusions with transcription factors or their protein stability domains can be considered as microbioreactors providing a way to directly monitor the stability of the luciferase labeled transcription factor or its domain in real-time. To understand principal advantages and/or limitations of these systems for the purposes of applied and fundamental research one needs to develop a quantitative description of their performance based on the determination of actual intracellular concentrations of the fusion proteins and rates of their production. In this work, the experimental data generated by means of luciferase activity calibration were used to calculate the steady-state intracellular concentrations of luciferase fusions in SH-SY5Y neuroblastoma cell lines stably expressing HIF1 ODD-luc and Neh2-luc proteins. For both reporters, the concentration of fusion proteins was determined as 60–80 nM, the values close to those for Michaelis constants for HIF prolyl hydroxylase (10–100 nM HIF) and the dissociation constant for Keap1-Nrf2 complex (50 nM), the parameters controlling rate-limiting steps of HIF1 ODD-luc and Neh2-luc reporter performance, respectively. New data allowed us to calculate the production rates and maximum concentrations for the fusion proteins under the conditions of irreversible activation and protein stabilization. The quantitative analysis of the Neh2-luc reporter performance employing the newly generated parameters explains the multi-order shift in the apparent activation constant versus the “real” dissociation constant determined for a known Nrf2 displacement activator using fluorescent polarization homogeneous assay with recombinant Keap1 and labeled Nrf2 peptide.
Keywords
About the authors
A. Yu. Khristichenko
D. Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunologyof Healtcare Ministry of Russia
Email: vitishkov@gmail.com
Russian Federation, Moscow, 117997
A. A. Poloznikov
D. Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunologyof Healtcare Ministry of Russia
Email: vitishkov@gmail.com
Russian Federation, Moscow, 117997
D. M. Hushpulian
D. Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunologyof Healtcare Ministry of Russia
Email: vitishkov@gmail.com
Russian Federation, Moscow, 117997
N. A. Smirnova
D. Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunologyof Healtcare Ministry of Russia
Email: vitishkov@gmail.com
Russian Federation, Moscow, 117997
A. A. Zakhariants
Innovations and High Technologies MSU Ltd
Email: vitishkov@gmail.com
Russian Federation, Moscow, 109559
S. V. Kazakov
Department of Chemistry and Physical Sciences, Dyson College, Pace University, Pleasantville
Email: vitishkov@gmail.com
United States, NY, 10570
V.I. Tishkov
Innovations and High Technologies MSU Ltd; Moscow State University, Department of Chemistry; A.N. Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology”of the Russian Academy of Sciences
Author for correspondence.
Email: vitishkov@gmail.com
Russian Federation, Moscow, 109559; Moscow, 119991; Moscow, 119071
I. G. Gazaryan
D. Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunologyof Healtcare Ministry of Russia; Innovations and High Technologies MSU Ltd; Moscow State University, Department of Chemistry
Email: vitishkov@gmail.com
Russian Federation, Moscow, 117997; Moscow, 109559; Moscow, 119991
Supplementary files
